Literature DB >> 20104243

Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2).

Nils Rahner1, Verena Steinke, Brigitte Schlegelberger, Sylviane Olschwang, François Eisinger, Pierre Hutter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20104243      PMCID： PMC2987434          DOI： 10.1038/ejhg.2009.232

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  5 in total

Review 1.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

2.  Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.

Authors:  Elena Stoffel; Bhramar Mukherjee; Victoria M Raymond; Nabihah Tayob; Fay Kastrinos; Jennifer Sparr; Fei Wang; Prathap Bandipalliam; Sapna Syngal; Stephen B Gruber
Journal:  Gastroenterology       Date:  2009-07-18       Impact factor: 22.682

3.  Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.

Authors:  M B Loughrey; P M Waring; A Tan; M Trivett; S Kovalenko; V Beshay; M-A Young; G McArthur; A Boussioutas; A Dobrovic
Journal:  Fam Cancer       Date:  2007-04-24       Impact factor: 2.375

Review 4.  Genetic testing in gastroenterology: Lynch syndrome.

Authors:  Shilpa Grover; Sapna Syngal
Journal:  Best Pract Res Clin Gastroenterol       Date:  2009       Impact factor: 3.043

Review 5.  Prognostic value of Y deletion analysis: what is the clinical prognostic value of Y chromosome microdeletion analysis?

Authors:  C Krausz; L Quintana-Murci; K McElreavey
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918
  5 in total
  5 in total

1.  The challenge of implementing genetic tests with clinical utility while avoiding unsound applications.

Authors:  Martina C Cornel; Carla G van El; Pascal Borry
Journal:  J Community Genet       Date:  2012-10-09

2.  Clinical utility gene card for: familial adenomatous polyposis (FAP) and attenuated FAP (AFAP).

Authors:  Stefan Aretz; Hans F A Vasen; Sylviane Olschwang
Journal:  Eur J Hum Genet       Date:  2011-02-02       Impact factor: 4.246

3.  Patient compliance based on genetic medicine: a literature review.

Authors:  Kai Insa Schneider; Jörg Schmidtke
Journal:  J Community Genet       Date:  2013-08-10

4.  A Rare MSH2 Variant as a Candidate Marker for Lynch Syndrome II Screening in Tunisia: A Case of Diffuse Gastric Carcinoma.

Authors:  Maria Kabbage; Jihenne Ben Aissa-Haj; Houcemeddine Othman; Amira Jaballah-Gabteni; Sarra Laarayedh; Sahar Elouej; Mouna Medhioub; Haifa Tounsi Kettiti; Amal Khsiba; Moufida Mahmoudi; Houda BelFekih; Afifa Maaloul; Hassen Touinsi; Lamine Hamzaoui; Emna Chelbi; Sonia Abdelhak; Mohamed Samir Boubaker; Mohamed Mousaddak Azzouz
Journal:  Genes (Basel)       Date:  2022-07-28       Impact factor: 4.141

5.  Unique Combination of Diamond-Blackfan Anemia and Lynch Syndrome in Adult Female: A Case Report.

Authors:  Aleksey S Tsukanov; Dmitriy Y Pikunov; Vitaly P Shubin; Aleksey A Barinov; Vladimir N Kashnikov; Yuri A Shelygin; Andrey D Kaprin; Elena V Filonenko; Dmitriy V Sidorov; Aleksey A Maschan; Galina A Novichkova; Liudmila A Yasko; Elena V Raykina; Aleksandr G Rumyantsev
Journal:  Front Oncol       Date:  2021-04-16       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.